{"DataElement":{"publicId":"2178058","version":"1","preferredName":"Person Hormone Receptor Status","preferredDefinition":"the hormonal receptor status of a patient.","longName":"PT_HORMREC_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2743989","version":"1","preferredName":"Person Hormone Receptor Description","preferredDefinition":"information related to the hormone receptor status or description, the ligand binding proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell, of a person","longName":"PER_HORMREC_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2743987","version":"1","preferredName":"Hormone Receptor Description","preferredDefinition":"Ligand binding proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell.  The hormone receptor can be cytoplasmic/nuclear, or associated with the cell membrane in the case of receptors whose ligands cannot penetrate the membrane.:Description; a statement that represents something in words.","longName":"C28154:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Receptor","conceptCode":"C28154","definition":"Ligand binding proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell.  The hormone receptor can be cytoplasmic/nuclear, or associated with the cell membrane in the case of receptors whose ligands cannot penetrate the membrane.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B78B132-7417-6593-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-22","modifiedBy":"ONEDATA","dateModified":"2008-04-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B78B132-7428-6593-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2178056","version":"1","preferredName":"Hormonal Status","preferredDefinition":"the hormonal receptor status.","longName":"HOR_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"ER-positive and/or PgR positive and NOT post-menopausal (tamoxifen is required.)","valueDescription":"ER-positive and/or PgR positive and NOT post-menopausal (tamoxifen is required.)","ValueMeaning":{"publicId":"2571763","version":"1","preferredName":"ER-positive and/or PgR positive and NOT post-menopausal (tamoxifen is required.)","longName":"2571763","preferredDefinition":"ER-positive and/or PgR positive and NOT post-menopausal (tamoxifen is required.)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E560-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-30","modifiedBy":"CAMPBELB","dateModified":"2004-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E33FB9-17B2-29D8-E034-0003BA12F5E7","beginDate":"2004-08-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"ER-positive and/or PgR positive and POST-MENOPAUSAL (tamoxifen or aromatase inhibitor is required)","valueDescription":"ER-positive and/or PgR positive and POST-MENOPAUSAL (tamoxifen or aromatase inhibitor is required)","ValueMeaning":{"publicId":"2571764","version":"1","preferredName":"ER-positive and/or PgR positive and POST-MENOPAUSAL (tamoxifen or aromatase inhibitor is required)","longName":"2571764","preferredDefinition":"ER-positive and/or PgR positive and POST-MENOPAUSAL (tamoxifen or aromatase inhibitor is required)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E561-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-30","modifiedBy":"CAMPBELB","dateModified":"2004-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E33FB9-17B6-29D8-E034-0003BA12F5E7","beginDate":"2004-08-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"ER-negative and PgR negative (neither tamoxifen nor aromatase inhibitor is permitted))","valueDescription":"ER-negative and PgR negative (neither tamoxifen nor aromatase inhibitor is permitted))","ValueMeaning":{"publicId":"2571765","version":"1","preferredName":"ER-negative and PgR negative (neither tamoxifen nor aromatase inhibitor is permitted))","longName":"2571765","preferredDefinition":"ER-negative and PgR negative (neither tamoxifen nor aromatase inhibitor is permitted))","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E562-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-30","modifiedBy":"CAMPBELB","dateModified":"2004-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E33FB9-17BA-29D8-E034-0003BA12F5E7","beginDate":"2004-08-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"ER-positive and/or PgR-positive","valueDescription":"ER-positive and/or PgR-positive","ValueMeaning":{"publicId":"2572030","version":"1","preferredName":"ER-positive and/or PgR-positive","longName":"2572030","preferredDefinition":"ER-positive and/or PgR-positive","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E66B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-20","modifiedBy":"CAMPBELB","dateModified":"2004-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6E70FDA-4036-36D3-E034-0003BA3F9857","beginDate":"2004-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-20","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"ER-negative and PgR-negative","valueDescription":"ER-negative and PgR-negative","ValueMeaning":{"publicId":"2572031","version":"1","preferredName":"ER-negative and PgR-negative","longName":"2572031","preferredDefinition":"ER-negative and PgR-negative","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E66C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-20","modifiedBy":"CAMPBELB","dateModified":"2004-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6E70FDA-403A-36D3-E034-0003BA3F9857","beginDate":"2004-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-20","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"ER- and PgR-negative","valueDescription":"ER- and PgR-negative","ValueMeaning":{"publicId":"3114701","version":"1","preferredName":"ER- and PgR-negative","longName":"3114701","preferredDefinition":"ER- and PgR-negative","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A16F110-7CEA-7076-E040-BB89AD4303CB","latestVersionIndicator":"Yes","beginDate":"2010-06-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A16F110-7D03-7076-E040-BB89AD4303CB","beginDate":"2010-06-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-28","modifiedBy":"ONEDATA","dateModified":"2010-06-28","deletedIndicator":"No"},{"value":"ER- and/or PgR-positive","valueDescription":"ER- and/or PgR-positive","ValueMeaning":{"publicId":"3114702","version":"1","preferredName":"ER- and/or PgR-positive","longName":"3114702","preferredDefinition":"ER- and/or PgR-positive","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A16F110-7D0D-7076-E040-BB89AD4303CB","latestVersionIndicator":"Yes","beginDate":"2010-06-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A16F110-7D26-7076-E040-BB89AD4303CB","beginDate":"2010-06-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-28","modifiedBy":"ONEDATA","dateModified":"2010-06-28","deletedIndicator":"No"},{"value":"ER positive and/or PgR positive and HER2 negative","valueDescription":"Positive Progesterone Receptor Status Positive Her2/Neu Status Negative Estrogen Receptor Status","ValueMeaning":{"publicId":"3799863","version":"1","preferredName":"Positive Progesterone Receptor Status Positive Her2/Neu Status Negative Estrogen Receptor Status","longName":"3799863","preferredDefinition":"Involving advantage or good.: Indicates the progesterone receptor level measured in a primary tumor or in metastases. (>=10 is positive if measured in fmols/mg cytosol protein; Otherwise use institutional standards): Involving advantage or good.: The presence or absence of Her2/Neu on a tissue sample.: Negative; involving disadvantage or harm.: The estrogen receptor level measured in a primary tumor or in metastases.  There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Progesterone Receptor Status","conceptCode":"C16149","definition":"Indicates the progesterone receptor level measured in a primary tumor or in metastases. (>=10 is positive if measured in fmols/mg cytosol protein; Otherwise use institutional standards)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"HER2/Neu Status","conceptCode":"C16152","definition":"The presence or absence of Her2/Neu on a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Estrogen Receptor Status","conceptCode":"C16150","definition":"The estrogen receptor level measured in a primary tumor or in metastases.  There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and is characterized by an ER+ status.  However, these two variants tend to overlap with respect to age, so it is possible for a young woman to have a \"late-onset\" form of breast cancer and for an older woman to have an \"early-onset\" variant of the disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0284F74-D3B3-718D-E040-BB89AD4302D3","latestVersionIndicator":"Yes","beginDate":"2013-06-27","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0284F74-D3CC-718D-E040-BB89AD4302D3","beginDate":"2013-06-27","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-06-27","modifiedBy":"ONEDATA","dateModified":"2013-06-27","deletedIndicator":"No"},{"value":"HER2 positive (either 3+ by IHC or FISH amplified)","valueDescription":"Positive Her2/Neu Status","ValueMeaning":{"publicId":"3799864","version":"1","preferredName":"Positive Her2/Neu Status","longName":"3799864","preferredDefinition":"Involving advantage or good.: The presence or absence of Her2/Neu on a tissue sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"HER2/Neu Status","conceptCode":"C16152","definition":"The presence or absence of Her2/Neu on a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0284F74-D3D9-718D-E040-BB89AD4302D3","latestVersionIndicator":"Yes","beginDate":"2013-06-27","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0284F74-D3F2-718D-E040-BB89AD4302D3","beginDate":"2013-06-27","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-06-27","modifiedBy":"ONEDATA","dateModified":"2013-06-27","deletedIndicator":"No"},{"value":"ER negative and PgR negative and HER2 negative","valueDescription":"Negative Progesterone Receptor Status Negative Her2/Neu Status Negative Estrogen Receptor Status","ValueMeaning":{"publicId":"3799865","version":"1","preferredName":"Negative Progesterone Receptor Status Negative Her2/Neu Status Negative Estrogen Receptor Status","longName":"3799865","preferredDefinition":"Negative; involving disadvantage or harm.: Indicates the progesterone receptor level measured in a primary tumor or in metastases. (>=10 is positive if measured in fmols/mg cytosol protein; Otherwise use institutional standards): Negative; involving disadvantage or harm.: The presence or absence of Her2/Neu on a tissue sample.: Negative; involving disadvantage or harm.: The estrogen receptor level measured in a primary tumor or in metastases.  There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Progesterone Receptor Status","conceptCode":"C16149","definition":"Indicates the progesterone receptor level measured in a primary tumor or in metastases. (>=10 is positive if measured in fmols/mg cytosol protein; Otherwise use institutional standards)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"HER2/Neu Status","conceptCode":"C16152","definition":"The presence or absence of Her2/Neu on a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negative","conceptCode":"C25247","definition":"Involving disadvantage or harm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Estrogen Receptor Status","conceptCode":"C16150","definition":"The estrogen receptor level measured in a primary tumor or in metastases.  There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and is characterized by an ER+ status.  However, these two variants tend to overlap with respect to age, so it is possible for a young woman to have a \"late-onset\" form of breast cancer and for an older woman to have an \"early-onset\" variant of the disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0284F74-D403-718D-E040-BB89AD4302D3","latestVersionIndicator":"Yes","beginDate":"2013-06-27","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E0284F74-D41C-718D-E040-BB89AD4302D3","beginDate":"2013-06-27","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-06-27","modifiedBy":"ONEDATA","dateModified":"2013-06-27","deletedIndicator":"No"},{"value":"Positive and > 18 months since diagnosis","valueDescription":"Positive Finding And Greater Than Eighteen Month Since Diagnosis","ValueMeaning":{"publicId":"6385469","version":"1","preferredName":"Positive Finding And Greater Than Eighteen Month Since Diagnosis","longName":"6385469","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than seventeen and less than nineteen and the quantity that it denotes.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.: Subsequent to; after.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Eighteen","conceptCode":"C111798","definition":"A natural number greater than seventeen and less than nineteen and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Since","conceptCode":"C45325","definition":"Subsequent to; after.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73017CB6-76B3-163A-E053-F662850A3A3A","latestVersionIndicator":"Yes","beginDate":"2018-08-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-08-09","modifiedBy":"ONEDATA","dateModified":"2018-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73017CB6-76CC-163A-E053-F662850A3A3A","beginDate":"2018-08-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-08-09","modifiedBy":"ONEDATA","dateModified":"2018-08-09","deletedIndicator":"No"},{"value":"Positive and <=18 months since diagnosis","valueDescription":"Positive Finding And Less Than or Equal To Eighteen Month Since Diagnosis","ValueMeaning":{"publicId":"6387369","version":"1","preferredName":"Positive Finding And Less Than or Equal To Eighteen Month Since Diagnosis","longName":"6387369","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A natural number greater than seventeen and less than nineteen and the quantity that it denotes.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.: Subsequent to; after.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Less Than or Equal To","conceptCode":"C61586","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Eighteen","conceptCode":"C111798","definition":"A natural number greater than seventeen and less than nineteen and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Since","conceptCode":"C45325","definition":"Subsequent to; after.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72F5220B-71C4-64F7-E053-F662850AEE50","latestVersionIndicator":"Yes","beginDate":"2018-08-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-08-09","modifiedBy":"ONEDATA","dateModified":"2018-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"72F5220B-71DD-64F7-E053-F662850AEE50","beginDate":"2018-08-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-08-09","modifiedBy":"ONEDATA","dateModified":"2018-08-09","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"2840098","version":"1","preferredName":"Negative Finding","longName":"2840098","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"635F3981-C786-F359-E040-BB89AD435EC5","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-20","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73037238-936D-1C77-E053-F662850A4247","beginDate":"2018-08-09","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-08-09","modifiedBy":"ONEDATA","dateModified":"2018-08-09","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"2581523","version":"1","preferredName":"Positive Finding","longName":"2581523","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B80-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2B3508C-F94D-38CB-E053-4EBD850ACD05","beginDate":"2020-10-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-28","modifiedBy":"ONEDATA","dateModified":"2020-10-28","deletedIndicator":"No"},{"value":"HER2 positive (either 3+ by IHC or ISH amplified)","valueDescription":"HER2 positive (either 3+ by IHC or ISH amplified)","ValueMeaning":{"publicId":"7717460","version":"1","preferredName":"HER2 positive (either 3+ by IHC or ISH amplified)","longName":"7717460","preferredDefinition":"HER2 positive (either 3+ by IHC or ISH amplified)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C68B7072-8B83-6D24-E053-4EBD850ACEF5","latestVersionIndicator":"Yes","beginDate":"2021-07-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-07-07","modifiedBy":"ONEDATA","dateModified":"2021-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C68B7072-8B9C-6D24-E053-4EBD850ACEF5","beginDate":"2021-07-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-07-07","modifiedBy":"ONEDATA","dateModified":"2021-07-07","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5612432","version":"1","preferredName":"Unknown","longName":"5612432","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"453584A6-34AF-15AA-E053-F662850A2541","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDA02558-34FC-21D1-E053-731AD00AC5BD","beginDate":"2022-11-16","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-11-16","modifiedBy":"GDEEN","dateModified":"2022-11-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC024767-0401-4DC3-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-11-13","modifiedBy":"GDEEN","dateModified":"2022-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811959","version":"1","longName":"Patient Char.","context":"CTEP"}]},{"publicId":"7765162","version":"1","longName":"PMI CDISC Harmonization","context":"PMI","ClassificationSchemeItems":[{"publicId":"13470911","version":"1","longName":"PMI CDISC EC Template v2.0","context":"PMI"},{"publicId":"10882766","version":"1","longName":"PMI CDISC EC Template v1.0","context":"PMI"}]}],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"HMRCSTAT","type":"Context Short Name","context":"PMI"}],"ReferenceDocuments":[{"name":"Hormonal status","type":"Preferred Question Text","description":"Hormonal status","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Hormone Receptor Status","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"HR Status","url":null,"context":"Alliance"},{"name":"PMI - 1","type":"Alternate Question Text","description":"Hormone Receptor Status","url":null,"context":"PMI"},{"name":"PMI - 2","type":"Alternate Question Text","description":"What is the hormone receptor status?","url":null,"context":"PMI"},{"name":"PMI - 3","type":"Alternate Question Text","description":"Hormone receptor status","url":null,"context":"PMI"}],"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC024767-0405-4DC3-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-11-13","modifiedBy":"GDEEN","dateModified":"2023-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}